Pulmatrix, Inc. current report, 20 December 2016

Pulmatrix, Inc. 8-K Summary

Business Context and Reporting Period

This Form 8-K was filed by Pulmatrix, Inc. on December 23, 2016, reporting an event that occurred on December 20, 2016. The filing addresses a regulatory notice regarding the company's stock listing status on The Nasdaq Capital Market.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the closing bid price of the company's common stock, which fell below the $1.00 per share minimum requirement for the last 30 consecutive business days prior to December 20, 2016.

Material Changes

The primary material change is the receipt of a delisting notice from Nasdaq. The company failed to meet the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2). Consequently, the company has been granted an initial compliance period of 180 calendar days, ending June 19, 2017, to regain compliance.

Outlook, Risks, and Contingencies

  • Compliance Path: To regain compliance within the initial 180-day period, the closing bid price must be at least $1.00 for a minimum of ten consecutive business days.
  • Extension Contingency: If compliance is not achieved by June 19, 2017, the company may be granted an additional 180-day period. This requires meeting all other initial listing standards (except bid price) and providing written notice of intent to cure the deficiency.
  • Risk: Failure to regain compliance within the allowed periods could result in the delisting of the company's common stock from The Nasdaq Capital Market.

Investor Verification Checklist

  • Verify the current closing bid price of Pulmatrix, Inc. common stock to assess progress toward the $1.00 threshold.
  • Monitor the company's stock price for ten consecutive business days to determine if the initial compliance condition is met.
  • Review subsequent filings to confirm if the company has notified Nasdaq of its intent to utilize the second 180-day compliance period if the initial deadline is missed.
  • Check for any reverse stock split announcements or other corporate actions intended to increase the share price.